Related Experiment Video

Updated: Aug 1, 2026

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Collagen stimulates more platelet prostaglandin endoperoxides in thrombosis

M Lagarde, M Dechavanne

    Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
    |April 1, 1977
    PubMed

    Insights

    Patients with thrombosis, including arterial and deep venous thrombosis (DVT), showed increased platelet prostaglandin cyclic endoperoxides synthesis. This suggests a link between elevated endoperoxides and thrombotic conditions.

    Area of Science:

    • Biochemistry
    • Hematology
    • Vascular Biology

    Background:

    • Platelets play a crucial role in hemostasis and thrombosis.
    • Prostaglandin cyclic endoperoxides are key mediators in platelet activation and aggregation.
    • Dysregulation of platelet function is implicated in various thrombotic disorders.

    Purpose of the Study:

    • To investigate the levels of platelet prostaglandin cyclic endoperoxides in patients with different types of thrombosis.
    • To determine if increased endoperoxide synthesis is associated with arterial thrombosis and deep venous thrombosis (DVT).

    Main Methods:

    • Measurement of platelet prostaglandin cyclic endoperoxides following collagen stimulation.
    • Analysis of patients with arterial thrombosis, recurrent DVT, and those undergoing total hip replacement (control group).

    Main Results:

    • Patients with post-surgical DVT synthesized significantly more platelet cyclic-endoperoxides compared to those without DVT.
    • Patients with arterial thrombosis and recurrent DVT exhibited higher ratios of platelet cyclic endoperoxides.
    • A subgroup of DVT patients showed markedly higher cyclic-endoperoxide synthesis, along with shortened platelet survival time.

    Conclusions:

    • Elevated synthesis of platelet prostaglandin cyclic endoperoxides is observed in a significant number of patients with thrombosis.
    • These findings suggest that increased platelet endoperoxide production may be a contributing factor or a marker for thrombotic events.
    • Further research is warranted to explore the therapeutic potential of targeting this pathway in thrombosis management.

    More Related Videos

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation09:13

    Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

    Published on: April 6, 2017

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation04:37

    Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

    Published on: May 23, 2025

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Structure and Function of Platelets01:18

    Structure and Function of Platelets

    The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
    Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
    Introduction to Hemostasis01:05

    Introduction to Hemostasis

    Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
    The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Extrinsic and Intrinsic Pathways of Hemostasis01:20

    Extrinsic and Intrinsic Pathways of Hemostasis

    Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
    The Extrinsic Pathway
    The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
    Clot Retraction and Fibrinolysis01:16

    Clot Retraction and Fibrinolysis

    After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.